Leth-Petersen, S; Petersen, IN; Jensen, AA; Bundgaard, C; Bæk, M; Kehler, J; Kristensen, JL. 5-HT2A/5-HT2C receptor pharmacology and intrinsic clearance of N-benzylphenethylamines modified at the primary site of metabolism ACS Chem. Neurosci., 16 Nov 2016, 7 (11), 1614–1619. 684 kB. https://doi.org/10.1021/acschemneuro.6b00265 #2
Leth-Petersen, S; Gabel-Jensen, C; Gillings, N; Lehel, S; Hansen, HD; Knudsen, GM; Kristensen, JL. Metabolic fate of hallucinogenic NBOMes Chem. Res. Toxicol., 19 Jan 2016, 29 (1), 96–100. 951 kB. https://doi.org/10.1021/acs.chemrestox.5b00450 #6, 14, 14 (SI) See also Supporting information LC,NMR
Poulie, CBM; Jensen, AA; Halberstadt, AL; Kristensen, JL. DARK Classics in Chemical Neuroscience: NBOMes ACS Chem. Neurosci., 2 Dec 2020, 11 (23), 3860-3869. 860 kB. https://doi.org/10.1021/acschemneuro.9b00528 #6
Marcher-Rørsted, E; Halberstadt, AL; Klein, AK; Chatha, M; Jademyr, S; Jensen, AA; Kristensen, JL. Investigation of the 2,5-dimethoxy motif in phenethylamine serotonin 2A receptor agonists ACS Chem. Neurosci., 26 Mar 2020, 11 (9), 1238-1244. 3.8 MB. https://doi.org/10.1021/acschemneuro.0c00129 #21 LC,MS,NMR
Duan, W; Cao, D; Wang, S; Cheng, J. Serotonin 2A receptor (5-HT2AR) agonists: Psychedelics and non-hallucinogenic analogues as emerging antidepressants Chem. Rev., 10 Jan 2024, 124 (1), 124–163. 12.6 MB. https://doi.org/10.1021/acs.chemrev.3c00375 #122